Advertisement
Skip to Content

Galapagos NV ADR GLPG Stock Quote

| Rating as of

NASDAQ: GLPG

Last close prices updated as of May 31, 2023, 5:31 AM EST | USD | BATS BZX Real-Time Price
  • Last Close 42.14
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Blend
  • Day Range 42.02  –  42.89
  • Year Range 36.17  –  58.67
  • Market Cap 2.7769 Bil
  • Volume / Avg 75.0 /  293,986.1
  • Price / Sales 4.71
  • Price / Book 1.01
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis GLPG

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics GLPG

Company Profile GLPG

Business Description

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact
Generaal De Wittelaan L11 A3
Mechelen, 2800, BEL
Industry Biotechnology
Employees 1,338

Related Articles GLPG

Competitors & Peers GLPG

Morningstar does not cover competitors or peers for this firm.

FAQs for Galapagos NV ADR Stock

No. GLPG does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

GLPG’s market cap is 2.78 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

GLPG’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

GLPG’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare GLPG’s historical performance against its industry peers and the overall market.